Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Leaders to Talk Policy with Congressional Leaders in D.C.

From the College  |  Issue: May 2017  |  April 19, 2017

Ask your senator and representative to: Eliminate IPAB via legislation or a joint resolution. Several pieces of legislation to repeal IPAB in both the House and Senate have achieved bipartisan support, including S.251, the Protecting Medicare from Executive Action Act of 2017, introduced by Sen. Ron Wyden (D-OR), which calls for the board’s repeal; S.J.Res.16, introduced by Sen. Ron Wyden; and H.J.Res.51, introduced by Rep. Raul Ruiz (D-CA) to authorize the board’s permanent repeal and S.260 and H.R.849, Protecting Seniors’ Access to Medicare Act of 2017, companion bills introduced by Majority Whip Sen. John Cornyn (R-TX) and Rep. Phil Roe, MD (R-TX), to rescind IPAB’s authorization.

Other 2017 Policy Priorities

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Ensure that any healthcare reform legislation prioritizes affordable coverage for chronically ill patients by
    • Including coverage for Americans with preexisting conditions;
    • Limiting copayments and out-of-pocket costs;
    • Covering children on a parent’s insurance until age 26;
    • Banning lifetime limits; and
    • Applying tax credits based on income.
  • Implement MACRA appropriately, which would include optimizing the Merit-Based Incentive Payment System (MIPS) for rheumatology care and supporting a rheumatology-inclusive Alternative Payment Model;
  • Apply proper value to cognitive specialty care, including new ICD-10 service codes that more adequately reflect rheumatology care in reimbursement;
  • Provide funding for FDA biosimilars review to ensure the introduction of additional safe and effective therapies and lower biologic drug costs;
  • Limit overly restrictive insurance practices, including step therapy, prior authorization and specialty drug tiers;
  • Provide adequate insurance coverage for biologic therapies, including coverage of administration for complex drugs and Medicare coverage of reimbursement at true ASP+6%; and
  • Advance greater transparency of Pharmacy Benefit Manager processes and accountability in how PBMs handle negotiated savings to promote more affordable drug pricing for patients.

Get Involved!
Remember: There’s power in numbers. You can join these ACR leaders in a Virtual Hill Day by visiting the ACR’s Legislative Action Center and letting your members of Congress know where you stand on the issues above. Fact sheets on each of these subjects is also available on the ACR’s website, so reach out to your representatives today!

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Capitol HillCDC Arthritis ProgramDepartment of Defense (DoD)FY2018 Defense Appropriations BillFY2018 Labor-HHA Appropriations BillIndependent Payment Advisory Board (IPAB)National Institutes of Health (NIH)policy issues

Related Articles

    Speaking Out for IPAB Repeal

    May 4, 2017

    On May 11, ACR President Sharad Lakhanpal, MBBS, MD, and other College members will be in Washington, D.C., to speak in support of proposed legislation or a joint resolution that would repeal the Independent Payment Advisory Board (IPAB). IPAB Defined In an attempt to control future Medicare expenditures, one element of the Patient Protection and…

    ACR Leaders & Volunteers Take the Issues to the Decision Makers

    May 19, 2017

    On May 11, ACR leaders representing the Board of Directors, Affiliate Society Council, Government Affairs Committee (GAC), Committee on Rheumatologic Care, RheumPAC Committee and Insurance Subcommittee went to Capitol Hill to advocate on behalf of the ACR/ARHP membership and our patients. The group, which represents 27 states and the District of Columbia, conducted meetings in…

    Healthcare Policy Prospects in the 118th Congress

    February 4, 2023

    The U.S. government remains divided. Democrats hold the White House and the Senate by one vote, and Republicans lead the House. Amid this division, the ACR is watching possible areas to advance healthcare legislation. Meet the committees and members with the largest jurisdiction over healthcare policy.

    Learn How the ACR is Advancing Rheumatology on Capitol Hill

    October 7, 2011

    While you are at the 2011 ACR/ARHP Annual Scientific Meeting learning about the latest advancements in rheumatologic care, stop by the Advocacy kiosk at the ACR Resource Center to discuss the latest developments in health policy. Currently, medicine is on the verge of great change with Congress discussing everything from physician payment reform to cuts to biomedical research and medical liability reform. The ACR advocates on behalf of the rheumatology profession and our patients and is actively pursuing the following issues:

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences